The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmitz, I.
Right arrow Articles by Kirchhoff, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitz, I.
Right arrow Articles by Kirchhoff, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
The Journal of Immunology, 2004, 172: 2194-2200.
Copyright © 2004 by The American Association of Immunologists

Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort1

Ingo Schmitz*,{dagger}, Heiko Weyd*, Andreas Krueger2,*, Sven Baumann*, Stefanie C. Fas*, Peter H. Krammer3,* and Sabine Kirchhoff4,*

* Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany; and {dagger} Institute of Molecular Medicine, University of Dusseldorf, Dusseldorf, Germany

In the early phase of an immune response, T cells are activated and acquire effector functions. Whereas these short term activated T cells are resistant to CD95-mediated apoptosis, activated T cells in prolonged culture are readily sensitive, leading to activation-induced cell death and termination of the immune response. The translation inhibitor, cycloheximide, partially overcomes the apoptosis resistance of short term activated primary human T cells. Using this model we show in this study that sensitization of T cells to apoptosis occurs upstream of mitochondria. Neither death-inducing signaling complex formation nor expression of Bcl-2 proteins is altered in sensitized T cells. Although the caspase-8 inhibitor c-FLIPlong was only slightly down-regulated in sensitized T cells, c-FLIPshort became almost undetectable. This correlated with caspase-8 activation and apoptosis. These data suggest that c-FLIPshort, rather than c-FLIPlong, confers resistance of T cells to CD95-mediated apoptosis in the context of immune responses.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-D. Klemke, D. Brenner, E.-M. Weiss, M. Schmidt, M. Leverkus, K. Gulow, and P. H. Krammer
Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Cancer Res., May 15, 2009; 69(10): 4175 - 4183.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Korporal, J. Haas, B. Balint, B. Fritzsching, A. Schwarz, S. Moeller, B. Fritz, E. Suri-Payer, and B. Wildemann
Interferon Beta-Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells
Arch Neurol, November 1, 2008; 65(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ferrarini, F. Delfanti, M. Gianolini, C. Rizzi, M. Alfano, A. Lazzarin, and P. Biswas
NF-{kappa}B Modulates Sensitivity to Apoptosis, Proinflammatory and Migratory Potential in Short- versus Long-Term Cultured Human {gamma}{delta} Lymphocytes
J. Immunol., November 1, 2008; 181(9): 5857 - 5864.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Ueffing, M. Schuster, E. Keil, K. Schulze-Osthoff, and I. Schmitz
Up-regulation of c-FLIPshort by NFAT contributes to apoptosis resistance of short-term activated T cells
Blood, August 1, 2008; 112(3): 690 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Zhang, K. Hopkins, and Y.-W. He
The Long Isoform of Cellular FLIP Is Essential for T Lymphocyte Proliferation through an NF-{kappa}B-Independent Pathway
J. Immunol., April 15, 2008; 180(8): 5506 - 5511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Haas, B. Fritzsching, P. Trubswetter, M. Korporal, L. Milkova, B. Fritz, D. Vobis, P. H. Krammer, E. Suri-Payer, and B. Wildemann
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis
J. Immunol., July 15, 2007; 179(2): 1322 - 1330.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Troeger, I. Schmitz, M. Siepermann, L. Glouchkova, U. Gerdemann, G. E. Janka-Schaub, K. Schulze-Osthoff, and D. Dilloo
Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL
Blood, July 1, 2007; 110(1): 384 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Meinander, T. S. Soderstrom, A. Kaunisto, M. Poukkula, L. Sistonen, and J. E. Eriksson
Fever-Like Hyperthermia Controls T Lymphocyte Persistence by Inducing Degradation of Cellular FLIPshort
J. Immunol., March 15, 2007; 178(6): 3944 - 3953.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
K. J. Rautajoki, E. M. Marttila, T. A. Nyman, and R. Lahesmaa
Interleukin-4 Inhibits Caspase-3 by Regulating Several Proteins in the Fas Pathway during Initial Stages of Human T Helper 2 Cell Differentiation
Mol. Cell. Proteomics, February 1, 2007; 6(2): 238 - 251.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. K. Samraj, D. Sohn, K. Schulze-Osthoff, and I. Schmitz
Loss of Caspase-9 Reveals Its Essential Role for Caspase-2 Activation and Mitochondrial Membrane Depolarization
Mol. Biol. Cell, January 1, 2007; 18(1): 84 - 93.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Fritzsching, N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death
Blood, November 15, 2006; 108(10): 3371 - 3378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Samraj, E. Keil, N. Ueffing, K. Schulze-Osthoff, and I. Schmitz
Loss of Caspase-9 Provides Genetic Evidence for the Type I/II Concept of CD95-mediated Apoptosis
J. Biol. Chem., October 6, 2006; 281(40): 29652 - 29659.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Golks, D. Brenner, P. H. Krammer, and I. N. Lavrik
The c-FLIP-NH2 terminus (p22-FLIP) induces NF-{kappa}B activation
J. Exp. Med., May 15, 2006; 203(5): 1295 - 1305.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Krueger, S. C. Fas, M. Giaisi, M. Bleumink, A. Merling, C. Stumpf, S. Baumann, D. Holtkotte, V. Bosch, P. H. Krammer, et al.
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
Blood, May 15, 2006; 107(10): 3933 - 3939.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Zeuner, F. Pedini, M. Signore, G. Ruscio, C. Messina, A. Tafuri, G. Girelli, C. Peschle, and R. De Maria
Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells
Blood, May 1, 2006; 107(9): 3495 - 3502.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Scotta, L. Tuosto, A. M. Masci, L. Racioppi, E. Piccolella, and L. Frasca
Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis
J. Leukoc. Biol., August 1, 2005; 78(2): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Poukkula, A. Kaunisto, V. Hietakangas, K. Denessiouk, T. Katajamaki, M. S. Johnson, L. Sistonen, and J. E. Eriksson
Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail
J. Biol. Chem., July 22, 2005; 280(29): 27345 - 27355.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Fritzsching, N. Oberle, N. Eberhardt, S. Quick, J. Haas, B. Wildemann, P. H. Krammer, and E. Suri-Payer
Cutting Edge: In Contrast to Effector T Cells, CD4+CD25+FoxP3+ Regulatory T Cells Are Highly Susceptible to CD95 Ligand- but Not to TCR-Mediated Cell Death
J. Immunol., July 1, 2005; 175(1): 32 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Golks, D. Brenner, C. Fritsch, P. H. Krammer, and I. N. Lavrik
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
J. Biol. Chem., April 15, 2005; 280(15): 14507 - 14513.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Bosque, J. Pardo, M{a} J. Martinez-Lorenzo, M. Iturralde, I. Marzo, A. Pineiro, M{a} A. Alava, J. Naval, and A. Anel
Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression
J. Leukoc. Biol., April 1, 2005; 77(4): 568 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. S. Misra, D. M. Jelley-Gibbs, J. Q. Russell, G. Huston, S. L. Swain, and R. C. Budd
Effector CD4+ T Cells Generate Intermediate Caspase Activity and Cleavage of Caspase-8 Substrates
J. Immunol., April 1, 2005; 174(7): 3999 - 4009.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Tseveleki, J. Bauer, E. Taoufik, C. Ruan, L. Leondiadis, S. Haralambous, H. Lassmann, and L. Probert
Cellular FLIP (Long Isoform) Overexpression in T Cells Drives Th2 Effector Responses and Promotes Immunoregulation in Experimental Autoimmune Encephalomyelitis
J. Immunol., December 1, 2004; 173(11): 6619 - 6626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.